The 2018 guideline addresses the practical management of patients with high blood cholesterol and related disorders.
Recommendations are based on the best available evidence from randomized controlled trials of cholesterol-lowering therapies and other sources of evidence.
This guideline is a full update of the 2013 ACC/AHA cholesterol guideline.